Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v3-EN
Language French English
Date Updated 2018-06-12 2018-04-16
Drug Identification Number 02238281 02238281
Brand name APO-SERTRALINE APO-SERTRALINE
Common or Proper name SERTRALINE SERTRALINE
Company Name APOTEX INC APOTEX INC
Ingredients SERTRALINE SERTRALINE
Strength(s) 50MG 50MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL & 250 BTL
ATC code N06AB N06AB
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-19 2018-02-19
Estimated end date 2018-06-29 2018-06-29
Actual end date 2018-06-11
Shortage status Resolved Actual shortage
Company comments
Health Canada comments